Compare Stocks: ESMC, AEMD, MBAI, and ZYXI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AEMD Aethlon Medical	$6.05 +0.7%	$3.77	$1.41 ▼ $36.83	$4.30M	1.21	4.91 million shs	14,978 shs
ESMC Escalon Medical	$0.15	$0.17	$0.14 ▼ $0.29	$1.11M	0.51	8,767 shs	N/A
MBAI MBody AI	$3.26 +8.3%	$6.46	$3.00 ▼ $27.44	$4.48M	0.66	19,877 shs	9,865 shs
ZYXI Zynex	$0.13	$0.12	$0.12 ▼ $2.82	$3.80M	0.99	2.32 million shs	N/A

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AEMD Aethlon Medical	0.00%	-6.20%	+287.82%	+70.90%	-84.03%
ESMC Escalon Medical	0.00%	-14.17%	-10.27%	-18.81%	-6.30%
MBAI MBody AI	0.00%	-0.91%	-50.61%	-61.83%	+325,999,900.00%
ZYXI Zynex	0.00%	0.00%	0.00%	0.00%	-91.55%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AEMD Aethlon Medical	$6.05 +0.7%	$3.77	$1.41 ▼ $36.83	$4.30M	1.21	4.91 million shs	14,978 shs
ESMC Escalon Medical	$0.15	$0.17	$0.14 ▼ $0.29	$1.11M	0.51	8,767 shs	N/A
MBAI MBody AI	$3.26 +8.3%	$6.46	$3.00 ▼ $27.44	$4.48M	0.66	19,877 shs	9,865 shs
ZYXI Zynex	$0.13	$0.12	$0.12 ▼ $2.82	$3.80M	0.99	2.32 million shs	N/A

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AEMD Aethlon Medical	0.00%	-6.20%	+287.82%	+70.90%	-84.03%
ESMC Escalon Medical	0.00%	-14.17%	-10.27%	-18.81%	-6.30%
MBAI MBody AI	0.00%	-0.91%	-50.61%	-61.83%	+325,999,900.00%
ZYXI Zynex	0.00%	0.00%	0.00%	0.00%	-91.55%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AEMD Aethlon Medical	1.50	Reduce	$1.50	-75.21% Downside
ESMC Escalon Medical	0.00	N/A	N/A	N/A
MBAI MBody AI	2.00	Hold	$10.00	206.75% Upside
ZYXI Zynex	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest ESMC, AEMD, MBAI, and ZYXI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/29/2026	MBAI MBody AI	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/28/2026	MBAI MBody AI	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$10.00
9/18/2026	AEMD Aethlon Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
8/18/2026	AEMD Aethlon Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$1.50
7/21/2026	MBAI MBody AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	AEMD Aethlon Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 10/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AEMD Aethlon Medical	N/A	N/A	N/A	N/A	$15.56 per share	N/A
ESMC Escalon Medical	$12.05M	0.09	$0.02 per share	7.74	$0.17 per share	0.88
MBAI MBody AI	N/A	N/A	$3.98 per share	0.82	$3.30 per share	N/A
ZYXI Zynex	$108.20M	0.04	$0.25 per share	0.51	$1.12 per share	0.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AEMD Aethlon Medical	-$7.15M	-$34.97	N/A	N/A	N/A	N/A	-123.08%	-99.28%	11/11/2026 (Estimated)
ESMC Escalon Medical	$110K	$0.11	1.37	N/A	N/A	16.17%	-21.42%	-6.72%	N/A
MBAI MBody AI	$4.14M	-$7.42	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	$2.99M	-$2.43	N/A	0.27	N/A	-68.35%	-804.30%	-36.67%	N/A

Latest ESMC, AEMD, MBAI, and ZYXI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2026	Q1 2027	AEMD Aethlon Medical	-$3.92	-$4.02	-$0.10	-$4.02	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AEMD Aethlon Medical	N/A	N/A	N/A	N/A	N/A
ESMC Escalon Medical	N/A	N/A	N/A	N/A	N/A
MBAI MBody AI	N/A	N/A	N/A	N/A	N/A
ZYXI Zynex	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AEMD Aethlon Medical	N/A	5.42	5.42
ESMC Escalon Medical	0.04	2.59	1.94
MBAI MBody AI	N/A	N/A	N/A
ZYXI Zynex	0.56	0.47	0.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AEMD Aethlon Medical	1.99%
ESMC Escalon Medical	N/A
MBAI MBody AI	1.07%
ZYXI Zynex	29.68%

Insider Ownership

Company	Insider Ownership
AEMD Aethlon Medical	0.60%
ESMC Escalon Medical	1.90%
MBAI MBody AI	0.48%
ZYXI Zynex	49.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AEMD Aethlon Medical	9	710,000	707,000	No Data
ESMC Escalon Medical	40	7.42 million	7.27 million	Not Optionable
MBAI MBody AI	85	1.38 million	1.37 million	N/A
ZYXI Zynex	770	30.39 million	15.41 million	No Data

ESMC, AEMD, MBAI, and ZYXI Headlines

Recent News About These Companies

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

July 21, 2026 | prnewswire.com

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm

July 13, 2026 | globenewswire.com

ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 21, 2026 | newsfilecorp.comN

ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.

April 16, 2026 | globenewswire.com

ZYNEX LEAD PLAINTIFF DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Zynex, Inc Investors to Contact the Firm Before the April 21st Lead Plaintiff Deadline

April 13, 2026 | globenewswire.com

Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline â€“ ZYXIQ

April 13, 2026 | globenewswire.com

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)

April 10, 2026 | globenewswire.com

ZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit â€” The Gross Law Firm

April 10, 2026 | globenewswire.com

ZYXIQ EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 9, 2026 | newsfilecorp.comN

ZYXIQ INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Zynex Investors of Securities Class Action Deadline on April 21, 2026

April 3, 2026 | prnewswire.com

ZYXIQ UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

April 1, 2026 | globenewswire.com

Zynex, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights - ZYXIQ

April 1, 2026 | prnewswire.com

ZYXI SHAREHOLDER ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 30, 2026 | prnewswire.com

ZYXIQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zynex, Inc. Securities Lawsuit â€” The Gross Law Firm

March 27, 2026 | globenewswire.com

ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 24, 2026 | prnewswire.com

ZYXIQ CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026

March 23, 2026 | newsfilecorp.comN

ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 20, 2026 | prnewswire.com

ZYXI SHAREHOLDER NOTICE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 19, 2026 | globenewswire.com

Shareholders that lost money on Zynex, Inc. (ZYXIQ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

March 18, 2026 | prnewswire.com

ZYXI INVESTOR ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

March 17, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESMC, AEMD, MBAI, and ZYXI Company Descriptions

Aethlon Medical NASDAQ:AEMD

$6.05 +0.04 (+0.67%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$6.12 +0.07 (+1.07%)

As of 10/9/2026 07:44 PM Eastern

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Escalon Medical OTCMKTS:ESMC

$0.15 0.00 (0.00%)

As of 10/9/2026

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

MBody AI NASDAQ:MBAI

$3.26 +0.25 (+8.31%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$3.26 0.00 (0.00%)

As of 10/9/2026 07:41 PM Eastern

MBody AI, Inc. (NASDAQ:MBAI) is a technology company focused on applying artificial intelligence to health, wellness and body-composition management. Its business centers on developing digital tools intended to help users better understand and manage aspects of their fitness, nutrition and overall well-being. The company’s products and services are designed to use data-driven insights and personalized recommendations to support individual health and wellness goals. Publicly available information about MBody AI’s specific product portfolio, operating geographies and leadership team is limited. MBody AI is an emerging company, and additional details about its commercial operations and corporate history may become available through future regulatory filings and company disclosures.

Zynex NASDAQ:ZYXI

$0.12 0.00 (0.00%)

As of 10/9/2026

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ESMC, AEMD, MBAI, and ZYXI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ESMC, AEMD, MBAI, and ZYXI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ESMC, AEMD, MBAI, and ZYXI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESMC, AEMD, MBAI, and ZYXI Company Descriptions

Aethlon Medical NASDAQ:AEMD

Escalon Medical OTCMKTS:ESMC

MBody AI NASDAQ:MBAI

Zynex NASDAQ:ZYXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ESMC, AEMD, MBAI, and ZYXI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ESMC, AEMD, MBAI, and ZYXI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ESMC, AEMD, MBAI, and ZYXI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESMC, AEMD, MBAI, and ZYXI Company Descriptions

Aethlon Medical NASDAQ:AEMD

Escalon Medical OTCMKTS:ESMC

MBody AI NASDAQ:MBAI

Zynex NASDAQ:ZYXI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools